Search research articles
Contact Us
Filters
Showing results (211-220 of 822) with videos related to
Page
of 83
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
April 20, 2025
Concurrent immunotherapy improves progression-free survival but increases toxicity in unresectable stage III NSCLC
Yiwei Qin, You Mo, Pengwei Li, et al.
Scientific Reports
|
March 21, 2025
Modulation of the tumor immune microenvironment by Interferon Regulatory Factor 8 enhances immunotherapy in lung adenocarcinoma
Wen Huo, Minxin Chen, Cheng Chang, et al.
BMC Cancer
|
March 15, 2025
Real-world data on immunotherapy combined with chemotherapy in elderly patients with extensive-stage small cell lung cancer
Ke Zhao, Shuangqing Lu, Jiling Niu, et al.
Medical Oncology (Northwood, London, England)
|
December 9, 2010
CIP2A is overexpressed in esophageal squamous cell carcinoma
Wei Qu, Wenjuan Li, Ling Wei, et al.
Chemosphere
|
November 12, 2010
Abnormal glucose regulation in pyrethroid pesticide factory workers
Jinsong Wang, Yueqian Zhu, Xiang Cai, et al.
Future Oncology (London, England)
|
March 17, 2018
Optimizing intrapleural bevacizumab dosing in non-small-cell lung cancer-mediated malignant pleural effusion: less is more
Dawei Chen, Xinyu Song, Yan Zhang, et al.
Therapeutic Advances in Medical Oncology
|
June 11, 2020
A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy
Xin Wang, Peiliang Wang, Zongxing Zhao, et al.
Journal of Cancer
|
April 15, 2020
A<sub>2A</sub>R Antagonism with DZD2269 Augments Antitumor Efficacy of Irradiation in Murine Model
Jiaqi Huang, Di Zhang, Yu Bai, et al.
Oncotargets and Therapy
|
August 20, 2016
The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review
Xiaoli Zhang, Jinming Yu, Minghuan Li, et al.
Oncotargets and Therapy
|
March 10, 2021
Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Ji Li, Wang Jing, Xiaoyang Zhai, et al.
Page
of 83
Search research articles
Search
Showing results (211-220 of 822) with videos related to
Sort By:
Page
of 83
Lung Cancer (Amsterdam, Netherlands)
|
April 20, 2025
Concurrent immunotherapy improves progression-free survival but increases toxicity in unresectable stage III NSCLC
Yiwei Qin, You Mo, Pengwei Li, et al.
Scientific Reports
|
March 21, 2025
Modulation of the tumor immune microenvironment by Interferon Regulatory Factor 8 enhances immunotherapy in lung adenocarcinoma
Wen Huo, Minxin Chen, Cheng Chang, et al.
BMC Cancer
|
March 15, 2025
Real-world data on immunotherapy combined with chemotherapy in elderly patients with extensive-stage small cell lung cancer
Ke Zhao, Shuangqing Lu, Jiling Niu, et al.
Medical Oncology (Northwood, London, England)
|
December 9, 2010
CIP2A is overexpressed in esophageal squamous cell carcinoma
Wei Qu, Wenjuan Li, Ling Wei, et al.
Chemosphere
|
November 12, 2010
Abnormal glucose regulation in pyrethroid pesticide factory workers
Jinsong Wang, Yueqian Zhu, Xiang Cai, et al.
Future Oncology (London, England)
|
March 17, 2018
Optimizing intrapleural bevacizumab dosing in non-small-cell lung cancer-mediated malignant pleural effusion: less is more
Dawei Chen, Xinyu Song, Yan Zhang, et al.
Therapeutic Advances in Medical Oncology
|
June 11, 2020
A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy
Xin Wang, Peiliang Wang, Zongxing Zhao, et al.
Journal of Cancer
|
April 15, 2020
A<sub>2A</sub>R Antagonism with DZD2269 Augments Antitumor Efficacy of Irradiation in Murine Model
Jiaqi Huang, Di Zhang, Yu Bai, et al.
Oncotargets and Therapy
|
August 20, 2016
The association of HMGB1 expression with clinicopathological significance and prognosis in Asian patients with colorectal carcinoma: a meta-analysis and literature review
Xiaoli Zhang, Jinming Yu, Minghuan Li, et al.
Oncotargets and Therapy
|
March 10, 2021
Estimating Survival in Patients with Non-Small-Cell Lung Cancer and Brain Metastases: A Verification of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA)
Ji Li, Wang Jing, Xiaoyang Zhai, et al.
Page
of 83